Illumina has hired Garret Hampton as executive vice president of clinical genomics, effective Jan. 9, 2017. Hampton will be responsible for Illumina's clinical genomics group, leading the reproductive and genetic health, oncology, and regulatory and medical affairs business units. He will also oversee CLIA labs and the chief medical officers organization. Previously, Hampton served as global head of oncology biomarker development and companion diagnostics at Genentech. He also co-led the Roche personalized medicine R&D initiative and chaired the Roche/Foundation Medicine joint R&D committee. In addition, he has held scientific and management roles at Celgene, the Genomics Institute of the Novartis Research Foundation, and the University of California, San Diego.